Perrigo Company plc (PRGO) financial statements (2022 and earlier)

Company profile

Business Address THE SHARP BUILDING
DUBLIN 2, D02 TY74
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,865642354551679622798
Cash and cash equivalents1,865642354551679622786
Short-term investments      13
Receivables6531,0541,2431,0731,1311,1761,282
Inventory, net of allowances, customer advances and progress billings1,0201,200967878807795839
Inventory1,0201,200967878807795839
Disposal group, including discontinued operation16      
Other undisclosed current assets306238192400203212264
Total current assets:3,8603,1342,7572,9022,8202,8053,183
Noncurrent Assets
Operating lease, right-of-use asset167186130
Property, plant and equipment864996903829833870932
Intangible assets, net (including goodwill)     8,58116,396
Goodwill     4,0494,972
Intangible assets, net (excluding goodwill)     4,53211,424
Deferred income tax assets7445
Other noncurrent assets378371400363410212225
Deferred tax assets, net  7240
Other undisclosed noncurrent assets5,1516,7587,1076,8897,5671,330(1,055)
Total noncurrent assets:6,5668,3558,5458,0818,80911,06516,538
TOTAL ASSETS:10,42611,48811,30110,98311,62913,87019,721
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8269789389059468831,180
Accounts payable411544520475450472748
Accrued liabilities279250229201231263246
Employee-related liabilities119175156132149116134
Taxes payable17932971163253
Debt6043831907057365
Disposal group, including discontinued operation33      
Deferred tax liabilities   81
Other undisclosed current liabilities126366394442420380368
Total current liabilities:1,5881,3821,3361,5371,4361,8361,694
Noncurrent Liabilities
Long-term debt and lease obligation2,9173,5283,3663,0523,2715,2255,247
Long-term debt, excluding current maturities2,9173,5283,3663,0523,2715,2255,247
Liabilities, other than long-term debt7699237964434308522,117
Deferred tax liabilities, net  3901,745
Deferred income tax liabilities239279281
Other liabilities530644515443430462372
Other undisclosed noncurrent liabilities   282322  
Total noncurrent liabilities:3,6864,4514,1623,7784,0226,0767,364
Total liabilities:5,2745,8335,4975,3155,4587,9139,058
Stockholders' equity
Stockholders' equity attributable to parent5,1525,6555,8045,6686,1715,95810,663
Common stock7,0437,1187,3607,4227,8938,1358,622
Accumulated other comprehensive income (loss)3639513985253(82)102
Retained earnings (accumulated deficit)(1,927)(1,858)(1,696)(1,838)(1,976)(2,095)1,938
Stockholders' equity attributable to noncontrolling interest  000(1)0
Total stockholders' equity:5,1525,6555,8045,6686,1715,95810,663
TOTAL LIABILITIES AND EQUITY:10,42611,48811,30110,98311,62913,87019,721

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
Revenues4,1395,0634,8374,7324,9465,2814,604
Revenue, net4,9465,2814,604
Cost of revenue
(Cost of Goods and Services Sold)
(2,723)(3,248)(3,064)(2,900)(2,967)(3,229)(2,891)
Gross profit:1,4161,8151,7731,8321,9802,0521,713
Operating expenses(1,006)(1,700)(1,569)(1,595)(1,381)(4,052)(965)
Other operating expense, net
(Other Expenses)
      (343)
Other undisclosed operating income      343
Operating income (loss):410115205237598(2,000)748
Nonoperating income (expense)(27)(17)66(6)10(24) 
Other nonoperating income (expense)(27)(17)66(6)10(23) 
Interest and debt expense(1)(20)(0)(1)(135)(1)(11)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   61  (489)
Income (loss) from continuing operations before equity method investments, income taxes:38378271291473(2,024)248
Income (loss) from equity method investments    0(4)(10)
Income (loss) from continuing operations before income taxes:38378271291473(2,028)238
Income tax expense (benefit)(390)(13)(25)(160)(161)836(120)
Net income (loss):(7)65246131313(1,193)118
Other undisclosed net income (loss) attributable to parent(62)(228)(100) (193)(2,820)10
Net income (loss) available to common stockholders, diluted:(69)(163)146131120(4,013)128

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
Net income (loss):(7)65246131313(1,193)118
Other comprehensive loss    (1)(67)(37)
Comprehensive income (loss):(7)65246131312(1,259)81
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(422)28(45)(168)142(2,820)10
Comprehensive income (loss), net of tax, attributable to parent:(428)93201(37)455(4,079)91

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: